Literature DB >> 26922891

Long-term survival of patients with multidrug-resistant tuberculosis according to treatment outcomes.

Nakwon Kwak1, Chul-Gyu Yoo1, Young Whan Kim1, Sung Koo Han1, Jae-Joon Yim2.   

Abstract

Survival times of 219 patients diagnosed with multidrug-resistant tuberculosis were calculated and treatment outcomes compared. Mean survival of 20 patients who failed to be cured was 109.8 months (95% confidence interval [CI], 87.4-132.1), shorter than that of 150 patients who were cured (140.4 months; 95% CI, 136.1-144.7; P < .01) and that of 28 patients classified as treatment completed (138.5 months; 95% CI, 131.0-146.1; P = .02). The results demonstrate that patients with multidrug-resistant tuberculosis with poor treatment outcomes live 9 years, on average.
Copyright © 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mean survival time; Mortality; Transmission; Treatment failure

Mesh:

Substances:

Year:  2016        PMID: 26922891     DOI: 10.1016/j.ajic.2016.01.012

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  4 in total

1.  Use of predicted vital status to improve survival analysis of multidrug-resistant tuberculosis cohorts.

Authors:  Meredith B Brooks; Salmaan Keshavjee; Irina Gelmanova; Nataliya A Zemlyanaya; Carole D Mitnick; Justin Manjourides
Journal:  BMC Med Res Methodol       Date:  2018-12-11       Impact factor: 4.615

2.  Fluoroquinolone resistance in multidrug-resistant tuberculosis patients.

Authors:  Hyun-Woo Lee; Jae-Joon Yim
Journal:  Korean J Intern Med       Date:  2019-02-25       Impact factor: 2.884

3.  Improvement of Nutritional Status among Tuberculosis Patients by Channa striata Supplementation: A True Experimental Study in Indonesia.

Authors:  Isa Ma'rufi; Khaidar Ali; Sigit Kusuma Jati; Anik Sukmawati; Kurnia Ardiansyah; Farida Wahyu Ningtyias
Journal:  Biomed Res Int       Date:  2020-01-11       Impact factor: 3.411

4.  Comparison of censoring assumptions to reduce bias in tuberculosis treatment cohort analyses.

Authors:  Meredith B Brooks; Carole D Mitnick; Justin Manjourides
Journal:  PLoS One       Date:  2020-10-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.